YD Bio Ltd (YDES) Reports Strong H1 2026 Growth but Remains Overvalued on Price-to-Sales Basis

YD Bio Ltd (YDES) Reports Strong H1 2026 Growth but Remains Overvalued on Price-to-Sales Basis — brisk.news